Abstract
Scoliosis is the most common developmental spinal deformity, but its genetic underpinnings remain only partially understood. To enhance the identification of scoliosis-related loci, we utilized whole body dual energy X-ray absorptiometry (DXA) scans from 57,887 individuals in the UK Biobank (UKB), and quantified spine curvature by applying deep learning models to segment then landmark vertebrae to measure the cumulative horizontal displacement of the spine from a central axis. On a subset of 120 individuals, our automated image-derived curvature measurements showed a correlation 0.92 with clinical Cobb angle assessments, supporting their validity as a proxy for scoliosis severity. To connect spinal curvature with its genetic basis we conducted a genome-wide association study (GWAS). Our quantitative imaging phenotype allowed us to identify 2 novel loci associated with scoliosis in a European population not seen in previous GWAS. These loci are in the gene SEM1/SHFM1 as well as on a lncRNA on chr 3 that is downstream of EDEM1 and upstream of GRM7. Genetic correlation analysis revealed significant overlap between our image-based GWAS and ICD-10 based GWAS in both the UKB and Biobank of Japan. We also showed that our quantitative GWAS had more statistical power to identify new loci than a case-control dataset with an order of magnitude larger sample size. Increased spine curvature was also associated with increased leg length discrepancy, reduced muscle strength and decreased bone density, and increased incidence of knee but not hip osteoarthritis. Our results illustrate the potential of using quantitative imaging phenotypes to uncover genetic associations that are challenging to capture with medical records alone and identify new loci for functional follow-up.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a grant from the Allen Discovery Center program, a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All our data comes from the UK Biobank study. The Ethics Advisory Committee of the UK Biobank gave ethical approval for our work under application ID: 65439.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The author's name was actually spelled correctly the first time
Data availability
All data used for this study were obtained from the UK Biobank under application number 65439. GWAS summary statistics are currently being uploaded to the GWAS catalog and are available at this Box link: https://utexas.box.com/s/5iqlxvhul0ri9torr89lspb66thmpcdl
